文献速递主动脉疾病内脏/肾动脉与血管畸形

移植物主动脉肠侵蚀和瘘的原位重建管理中的辅助措施

Adjuncts to the Management of Graft Aorto-Enteric Erosion and Fistula with in situ Reconstruction.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2021-11-01

这项回顾性单中心研究纳入2004至2020年66例移植物主动脉肠侵蚀(38例)和瘘(28例)原位重建患者,院内死亡42%,1年生存47.6%,3年生存45.6%,复发18%;年龄较大预测院内死亡,初级资深外科医生和开放腹腔与复发减少相关。

要点

  • 移植物主动脉肠侵蚀/瘘原位重建后院内死亡42%,1年生存47.6%,3年生存45.6%。
  • 主动脉肠瘘患者均表现为消化道出血,而侵蚀患者无出血(p < .001)。
  • 复发18%,初级资深外科医生和开放腹腔与复发减少相关。

核心结论

  • 移植物主动脉肠侵蚀/瘘原位重建后死亡率和复发率仍高,年龄较大预测院内死亡,直径≤2 cm肠壁缺损一期闭合缩短手术时间且不增加复发。

研究设计与样本

  • 回顾性单中心研究,纳入2004至2020年66例移植物主动脉肠侵蚀(n=38)和瘘(n=28,42%)患者。
  • 主要终点为院内死亡和主动脉肠侵蚀/瘘复发,生存采用Kaplan-Meier法估计,因素采用单变量±多变量Cox回归分析。
  • 2013年成立多学科团队会议,此后 primary operator 始终为资深外科医生。

主要发现

  • 主动脉肠瘘患者均表现为消化道出血,而侵蚀患者为0(p < .001)。
  • 50例(76%)出现感染征象,其中侵蚀37例 vs 瘘13例(p < .001)。
  • 因内移植物感染转诊随时间增加(n=15,23%;2013年前1例 vs 后14例;p = .002)。
  • 多数患者行完整移植物切除(n=52,79%),肾上阻断增加(n=21,32%;2013年前4例 vs 后17例;p = .015)。
  • 复杂内脏重建减少(n=31,47%;2013年前17例 vs 后14例;p = .055),开放腹腔增加(2013年前1例 vs 后22例;p < .001),缩短手术时间(p = .012)。

关键数值与推荐

  • 院内死亡达42%(n=28)。
  • 估计生存1年为47.6%(95%CI 35.0-59.1),3年为45.6%(95%CI 33.0-57.3),侵蚀高于瘘(log rank p = .029)。
  • 主动脉肠侵蚀/瘘复发12例(18%)。
  • 多变量分析中年龄较大预测院内死亡(p = .034)。
  • 单变量分析中初级资深外科医生(vs 初级)与复发减少相关(p = .003),开放腹腔(1例[4.4%] vs 初次筋膜闭合11例[26%])与复发减少相关(p = .045)。

临床怎么用

  • 作者认为年龄较大预测院内死亡。
  • 作者认为直径≤2 cm肠壁缺损一期闭合缩短手术时间且不增加主动脉肠瘘复发。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The objective of this retrospective single centre study was to determine whether different enteric reconstruction methods and adjuncts confer a benefit after in situ reconstructions (ISRs) of graft aorto-enteric erosion (AEnE) and fistula (AEnF). METHODS: Primary endpoints were in hospital mortality and AEnE/F recurrence. Survival was estimated using the Kaplan-Meier method and explanatory factors were searched for using uni- ± multivariable Cox regression analysis. In 2013, a multidisciplinary team meeting was convened and since then the primary operator has always been a senior surgeon. RESULTS: Sixty-six patients were treated for AEnE (n = 38) and AEnF (n = 28, 42%) from 2004 to 2020. All patients with AEnF presented with gastrointestinal bleeding (vs. 0 for AEnE; p < .001). Signs of infection were seen in 50 patients (76% [37 for AEnE vs. 13 for AEnF]; p < .001). Referrals for endograft infection increased over time (n = 15, 23%; one before 2013 vs. 14 after; p = .002). Most patients underwent complete graft excision (n = 52, 79%) with increasing suprarenal cross clamping (n = 21, 32%; four before 2013 vs. 17 after; p = .015). Complex visceral reconstructions decreased over time (n = 31, 47%; 17 before 2013 vs. 14 after; p = .055), while "open abdomens" (OAs) increased (one before 2013 vs. 22 after; p < .001), reducing operating time (p = .012). In hospital mortality reached 42% (n = 28). Estimated survival reached 47.6% (95% confidence interval [CI] 35.0 - 59.1) at one year and 45.6% (95% CI 33.0 - 57.3) at three years and was higher for AEnE than for AEnF (log rank p = .029). AEnE/F recurrence was noted in 12 patients (18%). Older age predicted in hospital mortality in multivariable analysis (p = .034). AEnE/F recurrence decreased with the presence of a primary senior surgeon (vs. junior; p = .003) and OA (1 [4.4%] vs. 11 [26%] for primary fascial closure; p = .045) in univariable analysis. CONCLUSION: Mortality and recurrence rates remain high after ISR of AEnE/F. Older age predicted in hospital mortality. Primary closure of enteric defects ≤ 2 cm in diameter reduced operating time without increasing the recurrence of AEnF.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Mauriac P, Francois MO, Marichez A, et al. Adjuncts to the Management of Graft Aorto-Enteric Erosion and Fistula with in situ Reconstruction. Eur J Vasc Endovasc Surg. 2021. PMID: 34736846. doi:10.1016/j.ejvs.2021.06.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。